Primary Site >> Colorectal Cancer
Gene >> ERCC2
| 1. | |||||||||||
| Journal: | Cancer Res. 1998 Feb 15;58(4):604-8. | ||||||||||
| Title: | Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. | ||||||||||
| Author: | Shen, M R|Jones, I M|Mohrenweiser, H | ||||||||||
| PMID: | 9485007 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Cancer. 1999 Mar 15;80(6):875-9. | ||||||||||
| Title: | Hepatitis B virus X protein inhibits nucleotide excision repair. | ||||||||||
| Author: | Jia, L|Wang, X W|Harris, C C | ||||||||||
| PMID: | 10074921 | ||||||||||
| 3. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1230-5. | ||||||||||
| Title: | Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. | ||||||||||
| Author: | Bai, C|Connolly, B|Metzker, M L|Hilliard, C A|Liu, X|Sandig, V|Soderman, A|Galloway, S M|Liu, Q|Austin, C P|Caskey, C T | ||||||||||
| PMID: | 10655513 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Res. 2001 Dec 15;61(24):8654-8. | ||||||||||
| Title: | A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. | ||||||||||
| Author: | Park, D J|Stoehlmacher, J|Zhang, W|Tsao-Wei, D D|Groshen, S|Lenz, H J | ||||||||||
| PMID: | 11751380 | ||||||||||
| 5. | |||||||||||
| Journal: | Am J Pharmacogenomics. 2003;3(2):73-88. | ||||||||||
| Title: | Implications of genetic testing in the management of colorectal cancer. | ||||||||||
| Author: | Stoehlmacher, Jan|Lenz, Heinz-Josef | ||||||||||
| PMID: | 12749725 | ||||||||||
| 6. | |||||||||||
| Journal: | Br J Cancer. 2003 Jul 21;89(2):333-7. | ||||||||||
| Title: | Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. | ||||||||||
| Author: | Mort, R|Mo, L|McEwan, C|Melton, D W | ||||||||||
| PMID: | 12865926 | ||||||||||
| 7. | |||||||||||
| Journal: | Int J Cancer. 2005 Mar 10;114(1):58-73. | ||||||||||
| Title: | Genotype phenotype correlations in Israeli colorectal cancer patients. | ||||||||||
| Author: | Starinsky, Sigal|Figer, Arie|Ben-Asher, Edna|Geva, Ravit|Flex, Dov|Fidder, Herma H|Zidan, Jamal|Lancet, Doron|Friedman, Eitan | ||||||||||
| PMID: | 15523694 | ||||||||||
| 8. | |||||||||||
| Journal: | BMC Cancer. 2005 Jan 28;5:12. | ||||||||||
| Title: | Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. | ||||||||||
| Author: | Yeh, Chih-Ching|Sung, Fung-Chang|Tang, Reiping|Chang-Chieh, Chung Rong|Hsieh, Ling-Ling | ||||||||||
| PMID: | 15679883 | ||||||||||
| 9. | |||||||||||
| Journal: | Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8. | ||||||||||
| Title: | Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. | ||||||||||
| Author: | Moreno, Victor|Gemignani, Federica|Landi, Stefano|Gioia-Patricola, Lydie|Chabrier, Amelie|Blanco, Ignacio|Gonzalez, Sara|Guino, Elisabet|Capella, Gabriel|Canzian, Federico | ||||||||||
| PMID: | 16609022 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Oncol. 2006 Jul;29(1):225-35. | ||||||||||
| Title: | Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. | ||||||||||
| Author: | Plasencia, C|Martinez-Balibrea, E|Martinez-Cardus, A|Quinn, D I|Abad, A|Neamati, N | ||||||||||
| PMID: | 16773204 | ||||||||||
| 11. | |||||||||||
| Journal: | BMC Cancer. 2006 Mar 16;6:67. | ||||||||||
| Title: | Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. | ||||||||||
| Author: | Skjelbred, Camilla Furu|Saebo, Mona|Wallin, Hakan|Nexo, Bjorn Andersen|Hagen, Per Christian|Lothe, Inger Marie Bowitz|Aase, Steinar|Johnson, Egil|Hansteen, Inger-Lise|Vogel, Ulla|Kure, Elin H | ||||||||||
| PMID: | 16542436 | ||||||||||
| 12. | |||||||||||
| Journal: | J Clin Oncol. 2007 Apr 1;25(10):1247-54. | ||||||||||
| Title: | Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. | ||||||||||
| Author: | Ruzzo, Annamaria|Graziano, Francesco|Loupakis, Fotios|Rulli, Eliana|Canestrari, Emanuele|Santini, Daniele|Catalano, Vincenzo|Ficarelli, Rita|Maltese, Paolo|Bisonni, Renato|Masi, Gianluca|Schiavon, Gaia|Giordani, Paolo|Giustini, Lucio|Falcone, Alfredo|Toni | ||||||||||
| PMID: | 17401013 | ||||||||||
| 13. | |||||||||||
| Journal: | Pharmacogenomics. 2007 Dec;8(12):1693-703. | ||||||||||
| Title: | Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome. | ||||||||||
| Author: | Le Morvan, Valerie|Smith, Denis|Laurand, Armelle|Brouste, Veronique|Bellott, Ricardo|Soubeyran, Isabelle|Mathoulin-Pelissier, Simone|Robert, Jacques | ||||||||||
| PMID: | 18085999 | ||||||||||
| 14. | |||||||||||
| Journal: | Pharmacogenomics J. 2008 Aug;8(4):278-88. | ||||||||||
| Title: | Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. | ||||||||||
| Author: | Ruzzo, A|Graziano, F|Loupakis, F|Santini, D|Catalano, V|Bisonni, R|Ficarelli, R|Fontana, A|Andreoni, F|Falcone, A|Canestrari, E|Tonini, G|Mari, D|Lippe, P|Pizzagalli, F|Schiavon, G|Alessandroni, P|Giustini, L|Maltese, P|Testa, E|Menichetti, E T|Magnani, M | ||||||||||
| PMID: | 17549067 | ||||||||||
| 15. | |||||||||||
| Journal: | BMC Cancer. 2008 Feb 12;8:50. | ||||||||||
| Title: | ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. | ||||||||||
| Author: | Huang, Ming-Yii|Fang, Wei-Yu|Lee, Su-Chen|Cheng, Tian-Lu|Wang, Jaw-Yuan|Lin, Shiu-Ru | ||||||||||
| PMID: | 18267032 | ||||||||||
| 16. | |||||||||||
| Journal: | J Clin Oncol. 2008 Jun 1;26(16):2690-8. | ||||||||||
| Title: | Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. | ||||||||||
| Author: | Braun, Michael S|Richman, Susan D|Quirke, Philip|Daly, Catherine|Adlard, Julian W|Elliott, Faye|Barrett, Jennifer H|Selby, Peter|Meade, Angela M|Stephens, Richard J|Parmar, Mahesh K B|Seymour, Matthew T | ||||||||||
| PMID: | 18509181 | ||||||||||
| 17. | |||||||||||
| Journal: | Br J Cancer. 2008 Oct 7;99(7):1050-5. | ||||||||||
| Title: | Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy. | ||||||||||
| Author: | Pare, L|Marcuello, E|Altes, A|del Rio, E|Sedano, L|Salazar, J|Cortes, A|Barnadas, A|Baiget, M | ||||||||||
| PMID: | 18797464 | ||||||||||
| 18. | |||||||||||
| Journal: | Cancer Sci. 2009 Jul;100(7):1261-6. | ||||||||||
| Title: | Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. | ||||||||||
| Author: | Lai, Jiun-I|Tzeng, Cheng-Hwai|Chen, Po-Min|Lin, Jen-Kou|Lin, Tzu-Chen|Chen, Wei-Shone|Jiang, Jeng-Kae|Wang, Huann-Sheng|Wang, Wei-Shu | ||||||||||
| PMID: | 19432884 | ||||||||||
| 19. | |||||||||||
| Journal: | J Clin Oncol. 2009 Nov 20;27(33):5519-28. | ||||||||||
| Title: | Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial. | ||||||||||
| Author: | Braun, Michael S|Richman, Susan D|Thompson, Lindsay|Daly, Catherine L|Meade, Angela M|Adlard, Julian W|Allan, James M|Parmar, Mahesh K B|Quirke, Philip|Seymour, Matthew T | ||||||||||
| PMID: | 19858398 | ||||||||||
| 20. | |||||||||||
| Journal: | Tohoku J Exp Med. 2009 Jul;218(3):185-91. | ||||||||||
| Title: | Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population. | ||||||||||
| Author: | Sliwinski, Tomasz|Krupa, Renata|Wisniewska-Jarosinska, Maria|Pawlowska, Elzbieta|Lech, Justyna|Chojnacki, Jan|Blasiak, Janusz | ||||||||||
| PMID: | 19561388 | ||||||||||
| 21. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 2010 Jun;136(6):803-9. | ||||||||||
| Title: | The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens. | ||||||||||
| Author: | Artac, Mehmet|Bozcuk, Hakan|Pehlivan, Sacide|Akcan, Songul|Pehlivan, Mustafa|Sever, Tugce|Ozdogan, Mustafa|Savas, Burhan | ||||||||||
| PMID: | 19908066 | ||||||||||
| 22. | |||||||||||
| Journal: | Cancer Sci. 2010 Feb;101(2):530-5. | ||||||||||
| Title: | Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. | ||||||||||
| Author: | Chen, Yen-Chung|Tzeng, Cheng-Hwai|Chen, Po-Min|Lin, Jen-Kou|Lin, Tzu-Chen|Chen, Wei-Shone|Jiang, Jeng-Kae|Wang, Huann-Sheng|Wang, Wei-Shu | ||||||||||
| PMID: | 19922504 | ||||||||||
| 23. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2010 Aug;66(3):547-58. | ||||||||||
| Title: | Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines. | ||||||||||
| Author: | Nannizzi, Sara|Veal, Gareth J|Giovannetti, Elisa|Mey, Valentina|Ricciardi, Simona|Ottley, Christopher J|Del Tacca, Mario|Danesi, Romano | ||||||||||
| PMID: | 20020129 | ||||||||||
| 24. | |||||||||||
| Journal: | Br J Clin Pharmacol. 2010 Jan;69(1):58-66. | ||||||||||
| Title: | Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients. | ||||||||||
| Author: | Etienne-Grimaldi, Marie-Christine|Milano, Gerard|Maindrault-Goebel, Frederique|Chibaudel, Benoist|Formento, Jean-Louis|Francoual, Mireille|Lledo, Gerard|Andre, Thierry|Mabro, May|Mineur, Laurent|Flesch, Michel|Carola, Elisabeth|de Gramont, Aimery | ||||||||||
| PMID: | 20078613 | ||||||||||
| 25. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 2010 Oct;136(10):1517-25. | ||||||||||
| Title: | Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. | ||||||||||
| Author: | Wang, Jingwen|Zhao, Yang|Jiang, Jing|Gajalakshmi, Vendhan|Kuriki, Kiyonori|Nakamura, Seiichi|Akasaka, Susumu|Ishikawa, Hideki|Suzuki, Sadao|Nagaya, Teruo|Tokudome, Shinkan | ||||||||||
| PMID: | 20229274 | ||||||||||
| 26. | |||||||||||
| Journal: | Pharmacogenomics. 2010 Jun;11(6):747-61. | ||||||||||
| Title: | Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response. | ||||||||||
| Author: | Balboa, Emilia|Duran, Goretti|Lamas, Maria Jesus|Gomez-Caamano, Antonio|Celeiro-Munoz, Catuxa|Lopez, Rafael|Carracedo, Angel|Barros, Francisco | ||||||||||
| PMID: | 20504250 | ||||||||||
| 27. | |||||||||||
| Journal: | J Appl Genet. 2010;51(3):343-52. | ||||||||||
| Title: | Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. | ||||||||||
| Author: | Jelonek, K|Gdowicz-Klosok, A|Pietrowska, M|Borkowska, M|Korfanty, J|Rzeszowska-Wolny, J|Widlak, P | ||||||||||
| PMID: | 20720310 | ||||||||||
| 28. | |||||||||||
| Journal: | Clin Cancer Res. 2011 Mar 15;17(6):1632-40. | ||||||||||
| Title: | ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. | ||||||||||
| Author: | Yin, Ming|Yan, Jingrong|Martinez-Balibrea, Eva|Graziano, Francesco|Lenz, Heinz-Josef|Kim, Hyo-Jin|Robert, Jacques|Im, Seock-Ah|Wang, Wei-Shu|Etienne-Grimaldi, Marie-Christine|Wei, Qingyi | ||||||||||
| PMID: | 21278243 | ||||||||||
| 29. | |||||||||||
| Journal: | Int J Colorectal Dis. 2011 Oct;26(10):1257-64. | ||||||||||
| Title: | Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies. | ||||||||||
| Author: | Zhang, Ying|Ding, Dapeng|Wang, Xiaoxue|Zhu, Zhenglan|Huang, Meiyan|He, Xiaofeng | ||||||||||
| PMID: | 21541661 | ||||||||||
| 30. | |||||||||||
| Journal: | Curr Med Res Opin. 2011 Jul;27(7):1295-302. | ||||||||||
| Title: | Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. | ||||||||||
| Author: | Canbay, Emel|Cakmakoglu, Bedia|Zeybek, Umit|Sozen, Seyma|Cacina, Canan|Gulluoglu, Mine|Balik, Emre|Bulut, Turker|Yamaner, Sumer|Bugra, Dursun | ||||||||||
| PMID: | 21561390 | ||||||||||
| 31. | |||||||||||
| Journal: | Mol Diagn Ther. 2011 Oct 1;15(5):277-83. | ||||||||||
| Title: | Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers? | ||||||||||
| Author: | Farina Sarasqueta, Arantza|van Lijnschoten, Gesina|Lemmens, Valery E P P|Rutten, Harm J T|van den Brule, Adriaan J C | ||||||||||
| PMID: | 21958378 | ||||||||||
| 32. | |||||||||||
| Journal: | Mutagenesis. 2012 Mar;27(2):225-32. | ||||||||||
| Title: | Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls. | ||||||||||
| Author: | Slyskova, Jana|Naccarati, Alessio|Pardini, Barbara|Polakova, Veronika|Vodickova, Ludmila|Smerhovsky, Zdenek|Levy, Miroslav|Lipska, Ludmila|Liska, Vaclav|Vodicka, Pavel | ||||||||||
| PMID: | 22294771 | ||||||||||
| 33. | |||||||||||
| Journal: | J Clin Lab Anal. 2012 Jan;26(1):10-5. | ||||||||||
| Title: | ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis. | ||||||||||
| Author: | Lu, Xiaobo|Xiao, Sha|Jin, Cuihong|van der Straaten, Tahar|Li, Xiaoxia | ||||||||||
| PMID: | 24833529 | ||||||||||
| 34. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2012;13(7):3465-9. | ||||||||||
| Title: | GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population. | ||||||||||
| Author: | Li, Hui-Yan|Ge, Xin|Huang, Guang-Ming|Li, Kai-Yu|Zhao, Jing-Quan|Yu, Xi-Miao|Bi, Wen-Si|Wang, Yu-Lin | ||||||||||
| PMID: | 22994779 | ||||||||||
| 35. | |||||||||||
| Journal: | Clin Cancer Res. 2012 Nov 1;18(21):5878-87. | ||||||||||
| Title: | Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas. | ||||||||||
| Author: | Slyskova, Jana|Korenkova, Vlasta|Collins, Andrew R|Prochazka, Pavel|Vodickova, Ludmila|Svec, Jiri|Lipska, Ludmila|Levy, Miroslav|Schneiderova, Michaela|Liska, Vaclav|Holubec, Lubos|Kumar, Rajiv|Soucek, Pavel|Naccarati, Alessio|Vodicka, Pavel | ||||||||||
| PMID: | 22966016 | ||||||||||
| 36. | |||||||||||
| Journal: | Pharmacogenomics. 2012 Jul;13(10):1173-91. | ||||||||||
| Title: | Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients. | ||||||||||
| Author: | Cortejoso, Lucia|Lopez-Fernandez, Luis A | ||||||||||
| PMID: | 22909207 | ||||||||||
| 37. | |||||||||||
| Journal: | Zhonghua Zhong Liu Za Zhi. 2012 Jul;34(7):501-5. | ||||||||||
| Title: | [Relationship between single nucleotide polymorphism in repair gene XPD751 and prognosis in colorectal carcinoma patients]. | ||||||||||
| Author: | Chen, Ya-min|Wu, Xu-lan|Zhang, Li-wei|Xu, Xin|Liu, Ji-wei | ||||||||||
| PMID: | 22967467 | ||||||||||
| 38. | |||||||||||
| Journal: | Cancer. 2013 Mar 1;119(5):1106-12. | ||||||||||
| Title: | Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer. | ||||||||||
| Author: | Duldulao, Marjun P|Lee, Wendy|Nelson, Rebecca A|Ho, Joyce|Le, Maithao|Chen, Zhenbin|Li, Wenyan|Kim, Joseph|Garcia-Aguilar, Julio | ||||||||||
| PMID: | 23096768 | ||||||||||
| 39. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2013 Apr;71(4):843-51. | ||||||||||
| Title: | Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. | ||||||||||
| Author: | Lee, Kyung-Hun|Chang, Hye Jung|Han, Sae-Won|Oh, Do-Youn|Im, Seock-Ah|Bang, Yung-Jue|Kim, Sun Young|Lee, Keun-Wook|Kim, Jee Hyun|Hong, Yong Sang|Kim, Tae Won|Park, Young Suk|Kang, Won Ki|Shin, Sang Joon|Ahn, Joong Bae|Kang, Gyeong Hoon|Jeong, Seung-Yong|Pa | ||||||||||
| PMID: | 23314736 | ||||||||||
| 40. | |||||||||||
| Journal: | Clin Colorectal Cancer. 2013 Jun;12(2):122-7. | ||||||||||
| Title: | Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer. | ||||||||||
| Author: | Arienti, Chiara|Tesei, Anna|Verdecchia, Giorgio Maria|Framarini, Massimo|Virzi, Salvatore|Grassi, Antonio|Scarpi, Emanuela|Turci, Livia|Silvestrini, Rosella|Amadori, Dino|Zoli, Wainer | ||||||||||
| PMID: | 23332421 | ||||||||||
| 41. | |||||||||||
| Journal: | Int J Mol Sci. 2013 Feb 19;14(2):4121-34. | ||||||||||
| Title: | Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome. | ||||||||||
| Author: | Huang, Ming-Yii|Wang, Jaw-Yuan|Huang, Meng-Lin|Chang, Hui-Jen|Lin, Shiu-Ru | ||||||||||
| PMID: | 23429196 | ||||||||||
| 42. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2013 Jun;71(6):1463-72. | ||||||||||
| Title: | Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer. | ||||||||||
| Author: | Cortejoso, Lucia|Garcia, Maria I|Garcia-Alfonso, Pilar|Gonzalez-Haba, Eva|Escolar, Fernando|Sanjurjo, Maria|Lopez-Fernandez, Luis A | ||||||||||
| PMID: | 23543295 | ||||||||||
| 43. | |||||||||||
| Journal: | Mutat Res. 2013 Jul 4;755(1):42-8. | ||||||||||
| Title: | The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays. | ||||||||||
| Author: | Gdowicz-Klosok, Agnieszka|Widel, Maria|Rzeszowska-Wolny, Joanna | ||||||||||
| PMID: | 23669291 | ||||||||||
| 44. | |||||||||||
| Journal: | J Surg Oncol. 2013 Dec;108(7):457-64. | ||||||||||
| Title: | Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy. | ||||||||||
| Author: | Huang, Ming-Yii|Tsai, Hsiang-Lin|Lin, Chih-Hung|Huang, Ching-Wen|Ma, Cheng-Jen|Huang, Chun-Ming|Chai, Chee-Yin|Wang, Jaw-Yuan | ||||||||||
| PMID: | 23996617 | ||||||||||
| 45. | |||||||||||
| Journal: | Oncol Lett. 2013 Sep;6(3):648-654. | ||||||||||
| Title: | Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients. | ||||||||||
| Author: | Kumamoto, Kensuke|Ishibashi, Keiichiro|Okada, Norimichi|Tajima, Yusuke|Kuwabara, Kouki|Kumagai, Yoichi|Baba, Hiroyuki|Haga, Norihiro|Ishida, Hideyuki | ||||||||||
| PMID: | 24137384 | ||||||||||
| 46. | |||||||||||
| Journal: | Chirurgia (Bucur). 2013 Sep-Oct;108(5):711-8. | ||||||||||
| Title: | Lys751Gln XPD and Arg399Gln XRCC1 in Romanians. Association with sporadic colorectal cancer risk and different stages of carcinomas. | ||||||||||
| Author: | Procopciuc, L M|Osian, G | ||||||||||
| PMID: | 24157118 | ||||||||||
| 47. | |||||||||||
| Journal: | Onco Targets Ther. 2014 Jul 12;7:1255-60. | ||||||||||
| Title: | Lack of association between the XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis. | ||||||||||
| Author: | Zhang, Tao|Zhang, Dong-Ming|Zhao, Da|Hou, Xiao-Ming|Ma, Shou-Cheng|Liu, Xiao-Jun | ||||||||||
| PMID: | 25050067 | ||||||||||
| 48. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2014;15(22):9699-706. | ||||||||||
| Title: | The XPD Lys751Gln polymorphism has predictive value in colorectal cancer patients receiving oxaliplatin-based chemotherapy: a systemic review and meta-analysis. | ||||||||||
| Author: | Qian, Ying-Ying|Liu, Xin-You|Pei, Dong|Xu, Jia-Li|Shen, Hua|Chen, Xiao-Feng|Liu, Yi-Qian|Shen, Li-Zong|Shu, Yong-Qian | ||||||||||
| PMID: | 25520091 | ||||||||||
| 49. | |||||||||||
| Journal: | Sci Rep. 2014 Nov 5;4:6828. | ||||||||||
| Title: | Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. | ||||||||||
| Author: | Ruzzo, Annamaria|Graziano, Francesco|Galli, Fabio|Giacomini, Elisa|Floriani, Irene|Galli, Francesca|Rulli, Eliana|Lonardi, Sara|Ronzoni, Monica|Massidda, Bruno|Zagonel, Vittorina|Pella, Nicoletta|Mucciarini, Claudia|Labianca, Roberto|Ionta, Maria Teresa|V | ||||||||||
| PMID: | 25370899 | ||||||||||
| 50. | |||||||||||
| Journal: | Genes Nutr. 2014 Nov;9(6):430. | ||||||||||
| Title: | Meat-derived carcinogens, genetic susceptibility and colorectal adenoma risk. | ||||||||||
| Author: | Ho, Vikki|Peacock, Sarah|Massey, Thomas E|Ashbury, Janet E|Vanner, Stephen J|King, Will D | ||||||||||
| PMID: | 25231222 | ||||||||||
| 51. | |||||||||||
| Journal: | PLoS One. 2014 May 2;9(5):e96301. | ||||||||||
| Title: | The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis. | ||||||||||
| Author: | Du, Haina|Guo, Nannan|Shi, Bin|Zhang, Qian|Chen, Zhipeng|Lu, Kai|Shu, Yongqian|Chen, Tao|Zhu, Lingjun | ||||||||||
| PMID: | 24787743 | ||||||||||
| 52. | |||||||||||
| Journal: | Sci Rep. 2014 Feb 17;4:4112. | ||||||||||
| Title: | Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. | ||||||||||
| Author: | Ni, Min|Zhang, Wei-zhong|Qiu, Jin-rong|Liu, Fei|Li, Min|Zhang, Ya-jie|Liu, Qing|Bai, Jin | ||||||||||
| PMID: | 24531312 | ||||||||||
| 53. | |||||||||||
| Journal: | Mol Biol Rep. 2015 Mar;42(3):755-64. | ||||||||||
| Title: | Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. | ||||||||||
| Author: | Paszkowska-Szczur, Katarzyna|Scott, Rodney J|Gorski, Bohdan|Cybulski, Cezary|Kurzawski, Grzegorz|Dymerska, Dagmara|Gupta, Satish|van de Wetering, Thierry|Masojc, Bartlomiej|Kashyap, Aniruddh|Gapska, Paulina|Gromowski, Tomasz|Kladny, Jozef|Lubinski, Jan|De | ||||||||||
| PMID: | 25391773 | ||||||||||
| 54. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2015 Apr;75(4):763-72. | ||||||||||
| Title: | Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. | ||||||||||
| Author: | Joerger, M|Huitema, A D R|Boot, H|Cats, A|Doodeman, V D|Smits, P H M|Vainchtein, L|Rosing, H|Meijerman, I|Zueger, M|Meulendijks, D|Cerny, T D|Beijnen, J H|Schellens, J H M | ||||||||||
| PMID: | 25677447 | ||||||||||
| 55. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2015;16(2):713-8. | ||||||||||
| Title: | DNA repair gene polymorphisms do not predict response to radiotherapy-based multimodality treatment of patients with rectal cancer: a meta-analysis. | ||||||||||
| Author: | Guo, Cheng-Xian|Yang, Guo-Ping|Pei, Qi|Yin, Ji-Ye|Tan, Hong-Yi|Yuan, Hong | ||||||||||
| PMID: | 25684513 | ||||||||||
| 56. | |||||||||||
| Journal: | Cancer Biomark. 2015;15(4):413-23. | ||||||||||
| Title: | An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population. | ||||||||||
| Author: | Kabzinski, Jacek|Przybylowska, Karolina|Dziki, Lukasz|Dziki, Adam|Majsterek, Ireneusz | ||||||||||
| PMID: | 25835182 | ||||||||||
| 57. | |||||||||||
| Journal: | Anticancer Res. 2016 Apr;36(4):1657-63. | ||||||||||
| Title: | Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan. | ||||||||||
| Author: | Chang, Wen-Shin|Yueh, Te-Cheng|Tsai, Chia-Wen|Ji, Hong-Xue|Wu, Cheng-Nan|Wang, Shou-Cheng|Lai, Yi-Liang|Hsu, Shih-Wei|Hsieh, Ming-Hao|Hsiao, Chieh-Lun|Hung, Yi-Wen|Shih, Tzu-Ching|Bau, Da-Tian | ||||||||||
| PMID: | 27069143 | ||||||||||
| 58. | |||||||||||
| Journal: | Pharmacogenomics. 2016 Oct;17(15):1725-1732. | ||||||||||
| Title: | Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis. | ||||||||||
| Author: | Shahnam, Adel|Ridha, Zainab|Wiese, Michael D|Kichenadasse, Ganessan|Sorich, Michael J | ||||||||||
| PMID: | 27636246 | ||||||||||
| 59. | |||||||||||
| Journal: | Arab J Gastroenterol. 2016 Sep;17(3):117-120. | ||||||||||
| Title: | DNA repair genes polymorphisms and risk of colorectal cancer in Saudi patients. | ||||||||||
| Author: | Karam, Rehab A|Al Jiffry, Bilal O|Al Saeed, Mohamed|Abd El Rahman, Tamer M|Hatem, Mohamed|Amer, Mona G | ||||||||||
| PMID: | 27686263 | ||||||||||
| 60. | |||||||||||
| Journal: | Exp Mol Pathol. 2017 Feb;102(1):78-85. | ||||||||||
| Title: | ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt. | ||||||||||
| Author: | Kassem, Amira B|Salem, Salem Eid|Abdelrahim, Mohamed E|Said, Amira S A|Salahuddin, Ahmad|Hussein, Marwa Mahmoud|Bahnassy, Abeer A | ||||||||||
| PMID: | 28088319 | ||||||||||
| 61. | |||||||||||
| Journal: | World J Surg. 2017 Nov;41(11):2884-2897. | ||||||||||
| Title: | Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy. | ||||||||||
| Author: | Huang, Ming-Yii|Huang, Joh-Jong|Huang, Chun-Ming|Lin, Chih-Hung|Tsai, Hsiang-Lin|Huang, Ching-Wen|Chai, Chee-Yin|Lin, Chia-Yang|Wang, Jaw-Yuan | ||||||||||
| PMID: | 28608017 | ||||||||||
| 62. | |||||||||||
| Journal: | Biomed Res Int. 2018 Jan 15;2018:9651320. | ||||||||||
| Title: | The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis. | ||||||||||
| Author: | Liu, Jingwei|Li, Hao|Sun, Liping|Feng, Xue|Wang, Zhenning|Yuan, Yuan|Xing, Chengzhong | ||||||||||
| PMID: | 29568775 | ||||||||||
| 63. | |||||||||||
| Journal: | Mol Genet Genomic Med. 2018 Apr 17. | ||||||||||
| Title: | Polymorphisms of DNA repair genes are associated with colorectal cancer in patients with Lynch syndrome. | ||||||||||
| Author: | Kamiza, Abram B|Hsieh, Ling-Ling|Tang, Reiping|Chien, Huei-Tzu|Lai, Chih-Hsiung|Chiu, Li-Ling|Lo, Tsai-Ping|Hung, Kuan-Yi|You, Jeng-Fu|Wang, Wen-Chang|Hsiung, Chao A|Yeh, Chih-Ching | ||||||||||
| PMID: | 29664240 | ||||||||||